| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/17/2013 | US8536114 Macrocycles |
| 09/17/2013 | US8535899 Assay for identifying a modulator of HIF hydroxylase |
| 09/17/2013 | US8535892 Binding molecules for human factor VIII and factor VIII-like proteins |
| 09/17/2013 | CA2626921C Process and intermediates for the synthesis of caspofungin |
| 09/17/2013 | CA2555666C Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 09/12/2013 | WO2013133440A1 Cell proliferation inhibitor and solution for preserving cells or organs |
| 09/12/2013 | WO2013133032A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013132094A1 PEPTIDES BASED TARGETING OF THE PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA (PDGFRβ) AND CD276 |
| 09/12/2013 | WO2013131856A1 Antioxidant peptides, compositions comprising them and their uses |
| 09/12/2013 | WO2013106851A3 Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes |
| 09/12/2013 | US20130239238 Immunoglobulin Cleavage Fragments and Disease Indicators and Compositions for Detecting and Binding Such |
| 09/12/2013 | US20130237688 Multimodality agents for tumor imaging and therapy |
| 09/12/2013 | US20130237686 Methods and Compositions for the Rapid Synthesis of Radiometal-Labeled Probes |
| 09/12/2013 | US20130237685 Linear assemblies, branched assemblies, macrocycles and covalent bundles of functionalized bis-peptides |
| 09/12/2013 | US20130237484 Human-derived cell-permeable peptide bioactive peptide conjugate, and use thereof |
| 09/12/2013 | US20130237476 Adipose tissue targeted peptides |
| 09/12/2013 | US20130237473 Melanocortin Receptor-Specific Peptides |
| 09/12/2013 | US20130236888 Enzyme substrate comprising a functional dye and associated technology and methods |
| 09/12/2013 | DE102012203547A1 Antimikrobielle Peptide Antimicrobial peptides |
| 09/11/2013 | EP2636679A1 HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide |
| 09/11/2013 | EP2636412A2 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same |
| 09/11/2013 | CN103288928A Bacillus mojavensis, antifungal lipopeptide compound, and preparation as well as application thereof |
| 09/11/2013 | CN103288927A Polypeptide specifically bound to surface of SGC-7901 cell |
| 09/11/2013 | CN103288926A Tubulin polymerization agent polypeptide and application thereof |
| 09/11/2013 | CN103288925A Melittin antitone analogue and preparation method for same |
| 09/11/2013 | CN103288924A Catfish antimicrobial peptide mutant and preparation method thereof |
| 09/11/2013 | CN103288923A Large-scale preparation method of thymopentin acetate |
| 09/11/2013 | CN103288922A Tumor necrosis factor (TNF)-alpha polypeptide inhibitor and application thereof |
| 09/11/2013 | CN103288921A Polypeptide inhibitor of vascular endothelial growth factor 2 tyrosine kinase and application thereof |
| 09/11/2013 | CN103288920A Survivin-derived peptide and use thereof |
| 09/11/2013 | CN103288919A Receptor (SSTR2)-selective somatostatin antagonists |
| 09/11/2013 | CN102718842B Process for extracting colistin sulfate through precipitation method |
| 09/11/2013 | CN102286074B Targeted peptide NGR of CD13 (aminopeptidase N) and application thereof |
| 09/11/2013 | CN102286073B Heptapeptide capable of axially and specifically bonding with surface of tooth enamel and use thereof |
| 09/11/2013 | CN102268074B 18F-E[c(RGDyk)2], medicine box used for automatic production thereof, and preparation method and use of medicine box |
| 09/11/2013 | CN102174079B New assays for preimplantation factor and preimplantation factor peptides |
| 09/11/2013 | CN101432294B Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 09/10/2013 | US8530623 Proteasome-activating lightening peptides and compositions containing same |
| 09/10/2013 | US8530622 Proteasome-activating anti-aging peptides and compositions containing same |
| 09/10/2013 | US8530620 Radiolabelling reagents and methods |
| 09/10/2013 | US8530429 Brain tumor targeting peptides and methods |
| 09/10/2013 | US8530421 Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis |
| 09/10/2013 | US8530419 Process for the synchronization of ovulation for timed breeding without heat detection |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8529943 Angiopoietin derived peptides |
| 09/10/2013 | US8529904 Antigenic peptide comprising sequenc simimlarity to wilm's tumor-1 gene a nd gata-1 transcription factor for use as targeting tools in treatment of cell proliferative disorders; tissue targeted therapy |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | US8529881 Peptides for active anti-cytokine immunization |
| 09/10/2013 | CA2562157C Processes for preparing eptifibatide |
| 09/10/2013 | CA2529027C D-amino acid peptides |
| 09/10/2013 | CA2433394C Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 09/06/2013 | WO2013129926A1 Side-chain protected oligopeptide fragment condensation using subtilisins in organic solvents |
| 09/06/2013 | WO2013128003A1 N-terminally modified oligopeptides and uses thereof |
| 09/06/2013 | WO2013127829A1 Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs |
| 09/05/2013 | US20130231457 Preparation method for caspofungin |
| 09/05/2013 | US20130231294 Tdf-related compounds and analogs thereof, analogs and bioactive fragments |
| 09/05/2013 | US20130231289 Synthetic analogues of neural regeneration peptides |
| 09/05/2013 | US20130231251 Methods For Selective Targeting |
| 09/05/2013 | US20130230591 Peptide for use as a medicament, in particular for the treatment of cancer |
| 09/05/2013 | US20130230544 Novel immunostimulatory method |
| 09/05/2013 | US20130230526 Klebsiella antigens |
| 09/05/2013 | US20130230515 Myostatin binding agents |
| 09/05/2013 | US20130228449 Microwave-assisted peptide synthesis |
| 09/04/2013 | EP2634193A1 Side-chain protected oligopeptide fragment condensation using subtilisins in organic solvents |
| 09/04/2013 | EP2632939A2 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 09/04/2013 | EP2632935A1 Process for the manufacture of degarelix and its intermediates |
| 09/04/2013 | EP2632934A1 Process for the manufacture of degarelix and its intermediates |
| 09/04/2013 | EP2632272A2 Chromobacterium bioactive compositions and metabolites |
| 09/04/2013 | CN1980951B 抗微生物多肽 Antimicrobial peptides |
| 09/04/2013 | CN103282494A C18orf54 peptides and vaccines including the same |
| 09/04/2013 | CN103282374A Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 09/04/2013 | CN103275254A Beta-folding-peptide-based amphiphilic polypeptide molecule brush and preparation method thereof |
| 09/04/2013 | CN103275253A Elastin-like polypeptide based temperature-sensitive polymer molecule brush and preparation method thereof |
| 09/04/2013 | CN103275191A Method for largely and quick extracting tachyplesin peptide |
| 09/04/2013 | CN103275190A Small molecular polypeptide ZY13 and application thereof |
| 09/04/2013 | CN103275189A Cracking liquid for peptide resin, and application thereof in synthesizing somatostatin by solid phase cracking |
| 09/04/2013 | CN103275188A Radiolabeled T140 polypeptide compound, and preparing method and application thereof |
| 09/04/2013 | CN103275187A Analgesic peptide FI as well as genes and application thereof |
| 09/04/2013 | CN103275186A Polypeptide having kidney protection effect, and application thereof |
| 09/04/2013 | CN103275185A Matrix metal proteinase-2 polypeptide inhibitors and application thereof |
| 09/04/2013 | CN103275184A Matrix metal proteinase-2 polypeptide inhibitors and application thereof |
| 09/04/2013 | CN103275183A VEGFR2 tyrosine kinase inhibitor polypeptide 2 and application thereof |
| 09/04/2013 | CN103275182A CD8+T cell dominant epitopes based on toxoplasmagondii bradyzoite antigens |
| 09/04/2013 | CN103275181A Tuna ground meat polypeptide angiogenesis inhibiting factor as well as preparation method and application thereof |
| 09/04/2013 | CN103275180A Navodon septentrionalos fish head protein antioxidant peptide as well as preparation method and application thereof |
| 09/04/2013 | CN103275176A ACE inhibitory peptide and preparation method thereof |
| 09/04/2013 | CN103272219A Selective r-cadherin antagonists and methods |
| 09/04/2013 | CN102260324B Inflammation prophase chemotactic factor antagonistic peptide, preparation method thereof, and application thereof |
| 09/04/2013 | CN101687908B Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 09/04/2013 | CN101633689B Peptide selection method |
| 09/03/2013 | US8524861 Treatment of bacterial infections |
| 09/03/2013 | US8524668 Methods of protecting against apoptosis using lipopeptides |
| 09/03/2013 | US8524666 Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation |
| 09/03/2013 | CA2736921C Tumour-associated peptides that bind to mhc molecules |
| 09/03/2013 | CA2707767C Biologically active peptides |
| 09/03/2013 | CA2504963C Conjugates of tnf and a ligand of cd13 receptor in combination with interferon-gamma for treating cancer |
| 09/03/2013 | CA2398277C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 09/01/2013 | CA2807712A1 Methods for treating cancer |
| 08/29/2013 | WO2013126703A1 Reversibly crosslinked helical hydrogen bond surrogate macrocycles |
| 08/29/2013 | WO2013126017A1 Organogels and emulsions for biological and non-biological applications |